Seeking Alpha
  • The Scientist
    GILD CYT387 superior to INCY ruxolitinib. Ruxo should NOT have been approved by FDA. Look @ Youtube video Dr. Pardanani on ruxo. Ruxo is junk
    12/10/11
    Reply (5)
    • TruffelPig: What you think about the EXEl drug cabozantinide?
      12/10/11
    • The Scientist: EXEL made a HUGE mistake by ignoring the FDA on prostate CA trial design. May waste years of time/money on a trial FDA does not approve of.
      12/11/11
    • TruffelPig: I think their data are too good to ignore. Also, there are end points for other trials starting - this is just one of several.
      12/11/11
    • jsandresen1: Niether drugs are cures. The most exciting news could be Cornerstone's drug Zyflo, read this story. http://www.mpnforum.com
      3/15/12
    • TruffelPig: What is this for a sharp comment? Zyflo isn't a cure either and in addition has nothing to do with an anti cancer drug.
      3/15/12